Market Launch of PoET System – Pushing blood screening forward

Frankfurt/Main – GFE today unveiled its vision for the future of NAT testing in blood screening, the PoET® system. A fully automated instrument, sophisticated software and a series of NAT tests make up this powerful solution for blood screening laboratories. Out of...

PoET HIV CE-IVD marked

Frankfurt am Main, March 12, 2021. – GFE announced the CE-IVD approval of its PoET® HIV blood screening NAT test. The PCR kit is used on GFE’s new, fully integrated NAT testing solution, the PoET® System. With this NAT test GFE continues its tradition as a leading...